I haven’t read all the comments and missed the last 10 or
I haven’t read all the comments and missed the last 10 or so minutes of the call. But my takeaway:
Almost total focus on Covid right now to expedite enrollees in Cd12. The fact they have someone on the road until they achieve the remaining 45 or so patients is encouraging and a big step forward
Forming a team of doctors to be “ the face of Leronlimab” who have actually used the drug on their patients and can speak to physicians is a huge plus. They will act like a sales team but with more credibility to the doctors who have patients in need. They can answer very specific questions in a “doctor to doctor” way that most sales people cannot do.
The fact NP said we were number 4 or 5 on a hospitals priority list until our guy showed up should underline the criticality of a sales team and how some of these mediocre drugs with very little effectiveness make their way into treating covid patients and why small Biotech firms always face a headwind when they don’t have drugs already in the market and a sales team behind it.
I am glad NP mentioned why they have so many meetings with shareholders. We had this discussion just a day or two ago on this board and he confirmed my point. When the bulk of the buyers are in an OTC stock the company has to have these meetings constantly to try to keep everyone on the boat.
The OWS conversation was also important and that the head of it was in conversations with Cytodyn.that definitely opens financing opportunity should there be a need for fresh capital to significantly turn up the crank on manufacturing .
The CSO along with new hires will also get the BLA pieces together in a more knowledgeable way to read ice the chances for errors in the filings .
So, as expected, a progress report but no announcements . So I think going forward when we have the next meeting , everyone now knows why NP has these so we won’t have speculations on announcements going forward. Those will be in press release before or after the market closes..
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...
Continue Reading
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
Top 5 Most Recently Viewed Articles
Daktronics, Inc. to Announce Financial Results Soon Daktronics, Inc. (NASDAQ: DAKT) has announced that it will be releasing its financial results for the first quarter of fiscal year 2025. This announcement is scheduled for the morning before the market opens, reflecting the company's dedication to keeping investors informed. Details of the Conference Call On the day of...
Continue Reading
Sprouts Farmers Market Stock Reaches Unprecedented Heights Sprouts Farmers Market Inc. (NASDAQ: SFM) has achieved a remarkable milestone, with its stock soaring to an all-time high of $121. This is a testament to the company's impressive growth over the past year, showcasing a staggering 187.67% surge in stock value. Such a significant increase highlights the growing...
Continue Reading
Intelligent Platform Management Interface (IPMI) Market Overview The Intelligent Platform Management Interface (IPMI) market is set to undergo significant transformations in the upcoming years. Initially valued at USD 3.57 billion in 2023, it is projected to soar to USD 9.65 billion by 2032, showcasing an impressive compound annual growth rate (CAGR) of 11.68% from 2024...
Continue Reading
Exciting Developments from TScan Therapeutics TScan Therapeutics, Inc. (Nasdaq: TCRX) is a pioneering biotechnology company that is making strides in the field of cancer treatment. Their focus on T cell receptor (TCR)-engineered T cell therapies (TCR-T) has positioned them at the forefront of clinical-stage innovations. With a commitment to developing effective therapies...
Continue Reading
Groundbreaking Women’s Esports Event Highlights The Milk Cup has made monumental strides with its inaugural event showcasing female talent in esports, especially within the world of Fortnite. The finals brought together skilled women from across the industry and established a platform for competitive play among women in a traditionally male-dominated space. Team Moxie...
Continue Reading